Classes & Events News Get
Updates
Donate

Brain Tumor Center Expands Neurological Care

January 15, 2018

Thanks to a generous gift from the Westfield-based Glasser Foundation, the Gerald J. Glasser Brain Tumor Center is expanding the progressive, groundbreaking neurological care already provided at Overlook Medical Center through continued investment in the area of neuro-oncology.

Renowned neuro-oncologist Kurt Jaeckle, MD, and neurosurgeon Yaron Moshel, MD, serve as co-directors of this comprehensive brain tumor center, located in the heart of the Atlantic Neuroscience Institute at Overlook. With the adjacent Neuroscience Outpatient Center and Inpatient and Critical Care units, the fifth-floor area near the hospital’s main entrance allows patients to receive consultations, testing and care in one convenient location.

Gerald J. Glasser Brain Tumor Center features a multidisciplinary panel of experts who, together, review each patient’s medical history and create individualized treatment plans to address benign and cancerous tumors of the brain, skull base, spine and spinal cord.

“A brain tumor diagnosis is a traumatic event,” acknowledges Dr. Jaeckle. “We understand that, and we’re always working to give patients the chance to stay one step ahead of their disease.”

Currently, more than $2 million has been raised toward a $5 million goal to fund the relocation and expansion of the dedicated outpatient center; a conversion and relocation of a dedicated neuro-operating room; an advanced practice nurse, nurse navigator, research nurse and data coordinator; support programs, including integrative medicine, palliative care and social work; and educational outreach.

Drs. Jaeckle and Moshel are also dedicated to building a robust research program that will provide patients with the best access to groundbreaking medical trials and treatments. As a member of the National Cancer Institute Cooperative Group System and the Alliance for Clinical Trials in Oncology, the center is able to offer the latest cutting-edge treatments and most novel therapies available.

For the more than a 1,000 patients cared for each year, Gerald J. Glasser Brain Tumor Center delivers state-of-the-art care while easing minds, comforting families and keeping hope alive. On a national and even global level, countless patients stand to benefit from ongoing research that looks to revolutionize the field of neuro-oncology for years to come.